| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10044646 | HBV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS10050926 | HBV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS10050948 | HBV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS10040758 | HBV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS10040759 | HBV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS10045412 | HBV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS10045413 | HBV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS30013457 | HIV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS30009121 | HIV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
| TVIS30083847 | HIV | ENSG00000164418.22 | protein_coding | GRIK2 | No | No | 2898 | Q13002 Q8IY40 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIK2 |
|---|---|
| DrugBank ID | DB01496 |
| Drug Name | Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione |
| Target ID | BE0000826 |
| UniProt ID | Q13002 |
| Regulation Type | antagonist |
| PubMed IDs | 11264449; 10487207 |
| Citations | Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51.@@Krasowski MD, Harrison NL: General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci. 1999 Aug 15;55(10):1278-303. |
| Groups | Experimental; Illicit |
| Direct Classification | Trifluoromethylbenzenes |
| SMILES | FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1 |
| Pathways | |
| PharmGKB | |
| ChEMBL |
